Important upcoming dates to watch

[biopearl]

1. April 17th J and J first quarter release, if Imetelstat is still on list that would be a good thing (that would be an understatement)

2. April 25th ASCO program/abstract release--maybe some insight as to ongoing studies (unlikely) or a glimpse into early preclinical combination studies/AML (more likely)

3. June 1 ASCO starts

4. Q2 IMbark analysis to provide data for possible continuation agreement with J and J

5. Q3 Continuation decision

6. November ASH abstract title release

7. ASH (this is the big one)

8. Unknown--MDS data from part I should be completed by time continuation agreement and trigger enrollment in part II in positive

9. Unknown--Studies in AML and combination studies for solid tumors (completely nebulous)